13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-17, with 21 holding rows worth $270,288,000.
- Accession
- 0000919574-15-001784
- Filer
- CIK 1493215
- Filed
- 2015-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, 21 entries on the cover page, a total value of $270,288,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $270,288,000 with VALUE read as thousands by filing date, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerRTW MASTER FUND, LTD.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TARO PHARMACEUTICAL INDS LTD | M8737E108 | SHS | 267,883 | $39,698,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 340,395 | $33,018,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 2,131,808 | $29,973,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,261,361 | $27,498,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 1,622,633 | $19,877,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 1,064,247 | $19,635,000 | thousands by filing date | |
| ARROWHEAD RESEARCH CORP | 042797209 | COM | 2,610,000 | $19,262,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 1,115,981 | $18,380,000 | thousands by filing date | |
| ZS PHARMA INC | 98979G105 | Common Stock | 374,821 | $15,581,000 | thousands by filing date | |
| RELYPSA INC | 759531106 | Common Stock | 450,239 | $13,867,000 | thousands by filing date | |
| XENOPORT INC | 98411C100 | COM | 842,568 | $7,389,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 500,000 | $7,160,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 2,665,643 | $7,011,000 | thousands by filing date | |
| AVALANCHE BIOT | 05337G107 | Common Stock | 50,000 | $2,700,000 | thousands by filing date | |
| REPROS THERAPEUTICS INC | 76028H209 | COM | 229,364 | $2,287,000 | thousands by filing date | |
| CYTRX CORP | 232828509 | COM PAR $.001 | 705,000 | $1,932,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 204,000 | $1,603,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 843,851 | $1,553,000 | thousands by filing date | |
| LIPOCINE INC NEW | 53630X104 | CMN | 209,333 | $1,101,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 15,356 | $594,000 | thousands by filing date | |
| LPATH INC-CLASS A | 548910306 | CMN | 60,000 | $169,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-15-001784 | this filing | 2015-02-17 | acceptance time not in the bulk data set |